M

Matinas BioPharma Holdings

MTNB

0.15810
USD
-0.004
(-2.47%)
Market Closed
Volume
284
EPS
0
Div Yield
0
P/E
-1
Market Cap
18,510,232
OverviewSignalsIdeasNews
Related Instruments
A
ACAD
-0.020
(-0.11%)
19.000 USD
A
ASLN
-0.09150
(-13.23%)
0.60000 USD
A
AUPH
-0.28000
(-4.76%)
5.60000 USD
B
BIIB
-2.500
(-1.17%)
210.710 USD
BMY
0.620
(1.30%)
48.180 USD
GILD
0.470
(0.62%)
76.510 USD
K
KMDA
-0.17000
(-3.01%)
5.48000 USD
K
KRTX
0
(0%)
0.000000 USD
L
LIFE
0
(0%)
0.000000 USD
MRK
0.680
(0.60%)
113.800 USD
N
NUZE
-0.67000
(-11.26%)
5.28000 USD
S
SAVA
1.230
(5.53%)
23.490 USD
S
SCYX
-0.11000
(-5.14%)
2.03000 USD
S
SNDL
-0.07000
(-3.08%)
2.20000 USD
V
VERU
-0.04740
(-5.06%)
0.88900 USD
VRTX
9.75
(1.97%)
505.40 USD
News

Novo Nordisk Surges in Profit and Sales

5 months ago
Stocks news

Title: Matinas Biopharma Holdings Inc

Sector: Healthcare
Industry: Biotechnology
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.